Semaglutide is the active ingredient in two blockbuster medications: Ozempic (approved for type 2 diabetes management) and Wegovy (approved for chronic weight management). Despite being the same molecule, they are prescribed at different doses, covered differently by insurance, and used for distinct clinical purposes. This distinction is important for patients considering physician-supervised GLP-1 weight loss therapy.
Ozempic: The Diabetes Drug That Became Famous for Weight Loss
Ozempic was FDA-approved in December 2017 for the treatment of type 2 diabetes and cardiovascular risk reduction. Available doses are 0.5 mg, 1 mg, and 2 mg weekly. The observation that Ozempic produced significant weight loss in diabetic patients led to the development and approval of higher-dose semaglutide specifically for weight management. Many physicians prescribe Ozempic off-label for weight loss in non-diabetic patients, particularly when Wegovy is unavailable or not covered by insurance.
Wegovy: The Weight Loss Formulation
Wegovy was FDA-approved in June 2021 specifically for chronic weight management, at doses escalating to a maintenance dose of 2.4 mg weekly — higher than the maximum Ozempic dose. This higher dose produces greater appetite suppression and weight loss than lower doses. In the STEP 1 trial, patients on Wegovy 2.4 mg lost an average of 14.9% of body weight at 68 weeks, compared to 2.4% for placebo. Wegovy is indicated for adults with BMI ≥30, or ≥27 with a weight-related condition.
Insurance and Practical Considerations
- Ozempic: more likely to be covered for patients with type 2 diabetes; less coverage for obesity alone
- Wegovy: specifically covered for obesity management in some commercial plans; out-of-pocket cost can be $1,300+ per month without coverage
- Both require physician prescription and supervision for appropriate use
- Biosimilar competition and manufacturer discounts can lower cost significantly
Dr. Arpana Pillay at Vish Medical helps patients navigate the Wegovy vs. Ozempic decision based on medical indication, insurance coverage, and individual goals. Book your consultation today to get personalized guidance.